We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+23.69%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$6.79B
AUM Growth
+$377M
Cap. Flow
-$743M
Cap. Flow %
-10.93%
Top 10 Hldgs %
13.56%
Holding
361
New
33
Increased
100
Reduced
180
Closed
46

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$50.8M
2
DRI icon
Darden Restaurants
DRI
+$42M
3
PH icon
Parker-Hannifin
PH
+$41M
4
COR icon
Cencora
COR
+$26.6M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$25.7M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$56M
2
T icon
AT&T
T
+$48.7M
3
GILD icon
Gilead Sciences
GILD
+$48.6M
4
QDEL icon
QuidelOrtho
QDEL
+$36.3M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$32.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Financials 15.82%
3 Technology 13.99%
4 Industrials 13.07%
5 Consumer Discretionary 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AL
126
DELISTED
Air Lease Corp
AL
$21.4M 0.31%
729,256
+54,924
+8% +$1.47M
UNF icon
127
Unifirst Corp
UNF
$5.27B
$21.3M 0.31%
119,160
-25,141
-17% -$4.21M
GPK icon
128
Graphic Packaging
GPK
$3.54B
$21.3M 0.31%
1,523,577
-389,767
-20% -$5.24M
TXT icon
129
Textron
TXT
$15.2B
$21.1M 0.31%
641,340
+190,038
+42% +$5.61M
BPMC
130
DELISTED
Blueprint Medicines
BPMC
$21M 0.31%
269,049
+165,128
+159% +$11.2M
RDN icon
131
Radian Group
RDN
$4.91B
$21M 0.31%
1,352,386
-200,321
-13% -$2.96M
LAMR icon
132
Lamar Advertising Co
LAMR
$15.7B
$20.9M 0.31%
312,599
-82,638
-21% -$5.05M
CVSA
133
Covista Inc
CVSA
$4.32B
$20.9M 0.31%
669,742
-89,404
-12% -$2.79M
J icon
134
Jacobs Solutions
J
$17.3B
$20.8M 0.31%
296,952
-13,950
-4% -$941K
TRV icon
135
Travelers Companies
TRV
$78.7B
$20.8M 0.31%
181,984
-20,537
-10% -$2.16M
AMWD
136
DELISTED
American Woodmark
AMWD
$20.6M 0.3%
272,412
+3,280
+1% +$188K
GNRC icon
137
Generac Holdings
GNRC
$12.6B
$20.5M 0.3%
168,359
-146,226
-46% -$15.4M
EXAS
138
DELISTED
Exact Sciences
EXAS
$20.4M 0.3%
234,609
-29,857
-11% -$2.39M
SNBR
139
DELISTED
Sleep Number
SNBR
$20.3M 0.3%
488,109
-153,767
-24% -$4.89M
EGOV
140
DELISTED
NIC Inc
EGOV
$20.1M 0.3%
+876,322
New +$20.7M
AMN icon
141
AMN Healthcare
AMN
$1.28B
$20.1M 0.3%
444,171
+56,459
+15% +$2.7M
NBIX icon
142
Neurocrine Biosciences
NBIX
$16.5B
$20M 0.3%
164,251
-45,170
-22% -$4.99M
TT icon
143
Trane Technologies
TT
$106B
$20M 0.29%
224,943
-110,504
-33% -$9.61M
OC icon
144
Owens Corning
OC
$12.5B
$20M 0.29%
358,517
-36,249
-9% -$1.69M
THG icon
145
Hanover Insurance
THG
$7.84B
$19.8M 0.29%
195,129
-50,164
-20% -$4.92M
NVRI icon
146
Enviri
NVRI
$580M
$19.5M 0.29%
1,446,899
+232,383
+19% +$2.33M
AXP icon
147
American Express
AXP
$231B
$19.5M 0.29%
204,527
-21,015
-9% -$1.93M
CXO
148
DELISTED
CONCHO RESOURCES INC.
CXO
$19.3M 0.28%
+374,105
New +$20.7M
MTZ icon
149
MasTec
MTZ
$21.9B
$19.2M 0.28%
428,453
-200,062
-32% -$7.58M
T icon
150
AT&T
T
$167B
$19.2M 0.28%
840,244
-2,138,181
-72% -$48.7M
4 5
6
7 8

Similar funds

GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Rothschild & Co Asset Management US's Q2 2020 Portfolio in Review

As of Q2 2020, Rothschild & Co Asset Management US held 361 positions worth $6.79B, up 5.9% from $6.41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Rothschild & Co Asset Management US withdrew a net $743M in Q2 2020, closing 46 positions and reducing 180 holdings. Its most notable exit was Gilead Sciences, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Rothschild & Co Asset Management US opened a new position in AbbVie worth $56.6M.

  • Rothschild & Co Asset Management US's largest Q2 2020 buy was AbbVie: 576,811 shares worth $56.6M.
  • Rothschild & Co Asset Management US added most to Parker-Hannifin in Q2 2020, an estimated $41M increase.
  • Rothschild & Co Asset Management US's biggest Q2 2020 reduction was Procter & Gamble, cutting an estimated $56M.
  • Rothschild & Co Asset Management US fully exited Gilead Sciences in Q2 2020, selling an estimated $48.6M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 14% of its $6.79B portfolio in Q2 2020.
  • Rothschild & Co Asset Management US opened 33 new positions and closed 46 in Q2 2020.
  • Rothschild & Co Asset Management US's portfolio value rose 5.9% quarter-over-quarter to $6.79B.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.